肺高血圧症（PH）治療薬市場は、製薬業界における専門分野であり、肺動脈の高血圧を特徴とする、稀ではあるものの重篤な疾患群の治療に重点を置いています。肺高血圧症は5つのグループに分類され、グループ1（肺動脈性肺高血圧症、PAH）とグループ3（肺疾患に伴うPH、例えばPH-ILD）が主要な治療ターゲットです。市場には、経口薬、吸入薬、静脈内／皮下注射薬など、症状の改善、生活の質の向上、疾患の進行抑制を目的とした幅広い治療薬が含まれています。2025年までに世界のPH治療薬市場は100億米ドルから200億米ドルに達すると推定され、2030年までの年平均成長率（CAGR）は3.2%から6.5%と予測されています。PH-ILDに対する疾患認知度の高まり、標的療法の進歩、そして治療選択肢の拡大が成長を牽引していますが、市場は特許切れや高額な治療費といった課題に直面しています。肺高血圧症治療薬は、エンドセリン、一酸化窒素、プロスタサイクリンといった特定の経路を標的とし、肺血管抵抗を低下させ、血流を改善します。この業界は、希少疾患の治療薬開発への多額の研究開発投資を特徴としており、無症候性（クラスI）から重症（クラスIV）までの機能クラスにおける患者転帰の改善に重点を置いています。主要な薬剤クラスには、エンドセリン受容体拮抗薬（ERA）、ホスホジエステラーゼ5（PDE-5）阻害薬、プロスタサイクリン類似体、可溶性グアニル酸シクラーゼ（sGC）刺激薬、選択的IP受容体作動薬などがあります。ボセンタンやアンブリセンタンといった主要医薬品の特許満了に伴うジェネリック医薬品との競争、そして新たな経路を標的とするソタテルセプトのような革新的な治療法の導入が、市場形成に影響を与えています。希少疾病用医薬品指定など、希少疾患に対する規制上の優遇措置は開発を後押ししていますが、高額な費用と限られた患者層が課題となっています。市場は、認知度の高まり、診断技術の向上、そしてPH-ILDを含む適応症の拡大にも影響を受けています。
目次
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Pulmonary Hypertension Drugs Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Pulmonary Hypertension Drugs Market in North America (2020-2030)
8.1 Pulmonary Hypertension Drugs Market Size
8.2 Pulmonary Hypertension Drugs Market by End Use
8.3 Competition by Players/Suppliers
8.4 Pulmonary Hypertension Drugs Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Pulmonary Hypertension Drugs Market in South America (2020-2030)
9.1 Pulmonary Hypertension Drugs Market Size
9.2 Pulmonary Hypertension Drugs Market by End Use
9.3 Competition by Players/Suppliers
9.4 Pulmonary Hypertension Drugs Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
Chapter 10 Historical and Forecast Pulmonary Hypertension Drugs Market in Asia & Pacific (2020-2030)
10.1 Pulmonary Hypertension Drugs Market Size
10.2 Pulmonary Hypertension Drugs Market by End Use
10.3 Competition by Players/Suppliers
10.4 Pulmonary Hypertension Drugs Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Pulmonary Hypertension Drugs Market in Europe (2020-2030)
11.1 Pulmonary Hypertension Drugs Market Size
11.2 Pulmonary Hypertension Drugs Market by End Use
11.3 Competition by Players/Suppliers
11.4 Pulmonary Hypertension Drugs Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Pulmonary Hypertension Drugs Market in MEA (2020-2030)
12.1 Pulmonary Hypertension Drugs Market Size
12.2 Pulmonary Hypertension Drugs Market by End Use
12.3 Competition by Players/Suppliers
12.4 Pulmonary Hypertension Drugs Market Size by Type
Chapter 13 Summary For Global Pulmonary Hypertension Drugs Market (2020-2025)
13.1 Pulmonary Hypertension Drugs Market Size
13.2 Pulmonary Hypertension Drugs Market by End Use
13.3 Competition by Players/Suppliers
13.4 Pulmonary Hypertension Drugs Market Size by Type
Chapter 14 Global Pulmonary Hypertension Drugs Market Forecast (2025-2030)
14.1 Pulmonary Hypertension Drugs Market Size Forecast
14.2 Pulmonary Hypertension Drugs Application Forecast
14.3 Competition by Players/Suppliers
14.4 Pulmonary Hypertension Drugs Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Johnson & Johnson
15.1.1 Company Profile
15.1.2 Main Business and Pulmonary Hypertension Drugs Information
15.1.3 SWOT Analysis of Johnson & Johnson
15.1.4 Johnson & Johnson Pulmonary Hypertension Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.2 United Therapeutics
15.2.1 Company Profile
15.2.2 Main Business and Pulmonary Hypertension Drugs Information
15.2.3 SWOT Analysis of United Therapeutics
15.2.4 United Therapeutics Pulmonary Hypertension Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.3 Viatris
15.3.1 Company Profile
15.3.2 Main Business and Pulmonary Hypertension Drugs Information
15.3.3 SWOT Analysis of Viatris
15.3.4 Viatris Pulmonary Hypertension Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.4 Eli Lilly
15.4.1 Company Profile
15.4.2 Main Business and Pulmonary Hypertension Drugs Information
15.4.3 SWOT Analysis of Eli Lilly
15.4.4 Eli Lilly Pulmonary Hypertension Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.5 Liquidia
15.5.1 Company Profile
15.5.2 Main Business and Pulmonary Hypertension Drugs Information
15.5.3 SWOT Analysis of Liquidia
15.5.4 Liquidia Pulmonary Hypertension Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.6 GSK
15.6.1 Company Profile
15.6.2 Main Business and Pulmonary Hypertension Drugs Information
15.6.3 SWOT Analysis of GSK
15.6.4 GSK Pulmonary Hypertension Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.7 Bayer
15.7.1 Company Profile
15.7.2 Main Business and Pulmonary Hypertension Drugs Information
15.7.3 SWOT Analysis of Bayer
15.7.4 Bayer Pulmonary Hypertension Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.8 Gilead Sciences
15.8.1 Company Profile
15.8.2 Main Business and Pulmonary Hypertension Drugs Information
15.8.3 SWOT Analysis of Gilead Sciences
15.8.4 Gilead Sciences Pulmonary Hypertension Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.9 Merck & Co.
15.9.1 Company Profile
15.9.2 Main Business and Pulmonary Hypertension Drugs Information
15.9.3 SWOT Analysis of Merck & Co.
15.9.4 Merck & Co. Pulmonary Hypertension Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.10 Sun Pharma
15.10.1 Company Profile
15.10.2 Main Business and Pulmonary Hypertension Drugs Information
15.10.3 SWOT Analysis of Sun Pharma
15.10.4 Sun Pharma Pulmonary Hypertension Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.11 Teva Pharmaceuticals
15.11.1 Company Profile
15.11.2 Main Business and Pulmonary Hypertension Drugs Information
15.11.3 SWOT Analysis of Teva Pharmaceuticals
15.11.4 Teva Pharmaceuticals Pulmonary Hypertension Drugs Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Pulmonary Hypertension Drugs Report
Table Data Sources of Pulmonary Hypertension Drugs Report
Table Major Assumptions of Pulmonary Hypertension Drugs Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Pulmonary Hypertension Drugs Picture
Table Pulmonary Hypertension Drugs Classification
Table Pulmonary Hypertension Drugs Applications
Table Drivers of Pulmonary Hypertension Drugs Market
Table Restraints of Pulmonary Hypertension Drugs Market
Table Opportunities of Pulmonary Hypertension Drugs Market
Table Threats of Pulmonary Hypertension Drugs Market
Table Raw Materials Suppliers
Table Different Production Methods of Pulmonary Hypertension Drugs
Table Cost Structure Analysis of Pulmonary Hypertension Drugs
Table Key End Users
Table Latest News of Pulmonary Hypertension Drugs Market
Table Merger and Acquisition
Table Planned/Future Project of Pulmonary Hypertension Drugs Market
Table Policy of Pulmonary Hypertension Drugs Market
Table 2020-2030 North America Pulmonary Hypertension Drugs Market Size
Figure 2020-2030 North America Pulmonary Hypertension Drugs Market Size and CAGR
Table 2020-2030 North America Pulmonary Hypertension Drugs Market Size by Application
Table 2020-2025 North America Pulmonary Hypertension Drugs Key Players Revenue
Table 2020-2025 North America Pulmonary Hypertension Drugs Key Players Market Share
Table 2020-2030 North America Pulmonary Hypertension Drugs Market Size by Type
Table 2020-2030 United States Pulmonary Hypertension Drugs Market Size
Table 2020-2030 Canada Pulmonary Hypertension Drugs Market Size
Table 2020-2030 Mexico Pulmonary Hypertension Drugs Market Size
Table 2020-2030 South America Pulmonary Hypertension Drugs Market Size
Figure 2020-2030 South America Pulmonary Hypertension Drugs Market Size and CAGR
Table 2020-2030 South America Pulmonary Hypertension Drugs Market Size by Application
Table 2020-2025 South America Pulmonary Hypertension Drugs Key Players Revenue
Table 2020-2025 South America Pulmonary Hypertension Drugs Key Players Market Share
Table 2020-2030 South America Pulmonary Hypertension Drugs Market Size by Type
Table 2020-2030 Brazil Pulmonary Hypertension Drugs Market Size
Table 2020-2030 Argentina Pulmonary Hypertension Drugs Market Size
Table 2020-2030 Asia & Pacific Pulmonary Hypertension Drugs Market Size
Figure 2020-2030 Asia & Pacific Pulmonary Hypertension Drugs Market Size and CAGR
Table 2020-2030 Asia & Pacific Pulmonary Hypertension Drugs Market Size by Application
Table 2020-2025 Asia & Pacific Pulmonary Hypertension Drugs Key Players Revenue
Table 2020-2025 Asia & Pacific Pulmonary Hypertension Drugs Key Players Market Share
Table 2020-2030 Asia & Pacific Pulmonary Hypertension Drugs Market Size by Type
Table 2020-2030 China Pulmonary Hypertension Drugs Market Size
Table 2020-2030 India Pulmonary Hypertension Drugs Market Size
Table 2020-2030 Japan Pulmonary Hypertension Drugs Market Size
Table 2020-2030 South Korea Pulmonary Hypertension Drugs Market Size
Table 2020-2030 Southeast Asia Pulmonary Hypertension Drugs Market Size
Table 2020-2030 Australia Pulmonary Hypertension Drugs Market Size
Table 2020-2030 Europe Pulmonary Hypertension Drugs Market Size
Figure 2020-2030 Europe Pulmonary Hypertension Drugs Market Size and CAGR
Table 2020-2030 Europe Pulmonary Hypertension Drugs Market Size by Application
Table 2020-2025 Europe Pulmonary Hypertension Drugs Key Players Revenue
Table 2020-2025 Europe Pulmonary Hypertension Drugs Key Players Market Share
Table 2020-2030 Europe Pulmonary Hypertension Drugs Market Size by Type
Table 2020-2030 Germany Pulmonary Hypertension Drugs Market Size
Table 2020-2030 France Pulmonary Hypertension Drugs Market Size
Table 2020-2030 United Kingdom Pulmonary Hypertension Drugs Market Size
Table 2020-2030 Italy Pulmonary Hypertension Drugs Market Size
Table 2020-2030 Spain Pulmonary Hypertension Drugs Market Size
Table 2020-2030 Belgium Pulmonary Hypertension Drugs Market Size
Table 2020-2030 Netherlands Pulmonary Hypertension Drugs Market Size
Table 2020-2030 Austria Pulmonary Hypertension Drugs Market Size
Table 2020-2030 Poland Pulmonary Hypertension Drugs Market Size
Table 2020-2030 Russia Pulmonary Hypertension Drugs Market Size
Table 2020-2030 MEA Pulmonary Hypertension Drugs Market Size
Figure 2020-2030 MEA Pulmonary Hypertension Drugs Market Size and CAGR
Table 2020-2030 MEA Pulmonary Hypertension Drugs Market Size by Application
Table 2020-2025 MEA Pulmonary Hypertension Drugs Key Players Revenue
Table 2020-2025 MEA Pulmonary Hypertension Drugs Key Players Market Share
Table 2020-2030 MEA Pulmonary Hypertension Drugs Market Size by Type
Table 2020-2025 Global Pulmonary Hypertension Drugs Market Size by Region
Table 2020-2025 Global Pulmonary Hypertension Drugs Market Size Share by Region
Table 2020-2025 Global Pulmonary Hypertension Drugs Market Size by Application
Table 2020-2025 Global Pulmonary Hypertension Drugs Market Share by Application
Table 2020-2025 Global Pulmonary Hypertension Drugs Key Vendors Revenue
Figure 2020-2025 Global Pulmonary Hypertension Drugs Market Size and Growth Rate
Table 2020-2025 Global Pulmonary Hypertension Drugs Key Vendors Market Share
Table 2020-2025 Global Pulmonary Hypertension Drugs Market Size by Type
Table 2020-2025 Global Pulmonary Hypertension Drugs Market Share by Type
Table 2025-2030 Global Pulmonary Hypertension Drugs Market Size by Region
Table 2025-2030 Global Pulmonary Hypertension Drugs Market Size Share by Region
Table 2025-2030 Global Pulmonary Hypertension Drugs Market Size by Application
Table 2025-2030 Global Pulmonary Hypertension Drugs Market Share by Application
Table 2025-2030 Global Pulmonary Hypertension Drugs Key Vendors Revenue
Figure 2025-2030 Global Pulmonary Hypertension Drugs Market Size and Growth Rate
Table 2025-2030 Global Pulmonary Hypertension Drugs Key Vendors Market Share
Table 2025-2030 Global Pulmonary Hypertension Drugs Market Size by Type
Table 2025-2030 Pulmonary Hypertension Drugs Global Market Share by Type
Table Johnson & Johnson Information
Table SWOT Analysis of Johnson & Johnson
Table 2020-2025 Johnson & Johnson Pulmonary Hypertension Drugs Revenue Gross Profit Margin
Figure 2020-2025 Johnson & Johnson Pulmonary Hypertension Drugs Revenue and Growth Rate
Figure 2020-2025 Johnson & Johnson Pulmonary Hypertension Drugs Market Share
Table United Therapeutics Information
Table SWOT Analysis of United Therapeutics
Table 2020-2025 United Therapeutics Pulmonary Hypertension Drugs Revenue Gross Profit Margin
Figure 2020-2025 United Therapeutics Pulmonary Hypertension Drugs Revenue and Growth Rate
Figure 2020-2025 United Therapeutics Pulmonary Hypertension Drugs Market Share
Table Viatris Information
Table SWOT Analysis of Viatris
Table 2020-2025 Viatris Pulmonary Hypertension Drugs Revenue Gross Profit Margin
Figure 2020-2025 Viatris Pulmonary Hypertension Drugs Revenue and Growth Rate
Figure 2020-2025 Viatris Pulmonary Hypertension Drugs Market Share
Table Eli Lilly Information
Table SWOT Analysis of Eli Lilly
Table 2020-2025 Eli Lilly Pulmonary Hypertension Drugs Revenue Gross Profit Margin
Figure 2020-2025 Eli Lilly Pulmonary Hypertension Drugs Revenue and Growth Rate
Figure 2020-2025 Eli Lilly Pulmonary Hypertension Drugs Market Share
Table Liquidia Information
Table SWOT Analysis of Liquidia
Table 2020-2025 Liquidia Pulmonary Hypertension Drugs Revenue Gross Profit Margin
Figure 2020-2025 Liquidia Pulmonary Hypertension Drugs Revenue and Growth Rate
Figure 2020-2025 Liquidia Pulmonary Hypertension Drugs Market Share
Table GSK Information
Table SWOT Analysis of GSK
Table 2020-2025 GSK Pulmonary Hypertension Drugs Revenue Gross Profit Margin
Figure 2020-2025 GSK Pulmonary Hypertension Drugs Revenue and Growth Rate
Figure 2020-2025 GSK Pulmonary Hypertension Drugs Market Share
Table Bayer Information
Table SWOT Analysis of Bayer
Table 2020-2025 Bayer Pulmonary Hypertension Drugs Revenue Gross Profit Margin
Figure 2020-2025 Bayer Pulmonary Hypertension Drugs Revenue and Growth Rate
Figure 2020-2025 Bayer Pulmonary Hypertension Drugs Market Share
Table Gilead Sciences Information
Table SWOT Analysis of Gilead Sciences
Table 2020-2025 Gilead Sciences Pulmonary Hypertension Drugs Revenue Gross Profit Margin
Figure 2020-2025 Gilead Sciences Pulmonary Hypertension Drugs Revenue and Growth Rate
Figure 2020-2025 Gilead Sciences Pulmonary Hypertension Drugs Market Share
Table Merck & Co. Information
Table SWOT Analysis of Merck & Co.
Table 2020-2025 Merck & Co. Pulmonary Hypertension Drugs Revenue Gross Profit Margin
Figure 2020-2025 Merck & Co. Pulmonary Hypertension Drugs Revenue and Growth Rate
Figure 2020-2025 Merck & Co. Pulmonary Hypertension Drugs Market Share
Table Sun Pharma Information
Table SWOT Analysis of Sun Pharma
Table 2020-2025 Sun Pharma Pulmonary Hypertension Drugs Revenue Gross Profit Margin
Figure 2020-2025 Sun Pharma Pulmonary Hypertension Drugs Revenue and Growth Rate
Figure 2020-2025 Sun Pharma Pulmonary Hypertension Drugs Market Share
Table Teva Pharmaceuticals Information
Table SWOT Analysis of Teva Pharmaceuticals
Table 2020-2025 Teva Pharmaceuticals Pulmonary Hypertension Drugs Revenue Gross Profit Margin
Figure 2020-2025 Teva Pharmaceuticals Pulmonary Hypertension Drugs Revenue and Growth Rate
Figure 2020-2025 Teva Pharmaceuticals Pulmonary Hypertension Drugs Market Share
......
